MyFinsight
Home
Blog
About
Contact
Product Supplies
$1,267,076
(102.20%↑ Y/Y)
Training
$772,005
(432.71%↑ Y/Y)
Patient Procedures
$600,273
(1.27%↑ Y/Y)
Revenue
$2,639,353
(93.45%↑ Y/Y)
Gross profit
$1,766,491
(87.15%↑ Y/Y)
Cost of revenue
$872,862
(107.60%↑ Y/Y)
Net loss
-$876,274
(-15.29%↓ Y/Y)
Income from operations
$229,783
(70.26%↑ Y/Y)
Total operating
expenses
$1,536,708
(89.97%↑ Y/Y)
Total other expense
-$1,106,057
(-23.58%↓ Y/Y)
Change in the fair value
of derivative...
$1,084,492
(94485.73%↑ Y/Y)
Professional fees
$528,155
(59.21%↑ Y/Y)
General and
administrative
$475,812
(93.76%↑ Y/Y)
Advertising and marketing
$391,047
(148.57%↑ Y/Y)
Depreciation and
amortization expense
$97,694
(88.55%↑ Y/Y)
Officer compensation
$22,500
(0.00%↑ Y/Y)
Investor relations
$21,500
Interest expense
$2,190,549
(145.07%↑ Y/Y)
Back
Back
Income Statement
Regenerative Medical Technology Group Inc. (RMTG)
Regenerative Medical Technology Group Inc. (RMTG)
source: myfinsight.com